dr. M.V. Lukens

No picture available
m.v.lukens umcg.nl


  1. Direct Oral Anticoagulants in Antithrombin Deficiency: Initial Experience in a Single Center

    Bhoelan, B. S., Mulder, R., Lukens, M. V. & Meijer, K., 30-Aug-2020, In : Thrombosis and Haemostasis. 4 p.

    Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

  2. A boy with joint pain associated with emicizumab treatment: The importance of plasma level measurement

    Hooimeijer, H. L., Lukens, M. V., Verhagen, M. V., Meijer, K., Stein-Wit, M. A. & Tamminga, R. Y. J., 16-Apr-2020, In : Haemophilia. 26, 3, p. e138-e140 3 p.

    Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

  3. Effect of Lower von Willebrand Factor and Factor XI Levels on Treatment Success of the Levonorgestrel Intrauterine System or Endometrial Ablation in Heavy Menstrual Bleeding - An Explorative Study

    Brink, van den, M., Wiewel - Verschueren, S., Beelen, P., Borselen, J. W. V., Bongers, M. Y., Lukens, M., Dekker, J. H. & Meijer, K., 21-Jun-2019, In : Research and practice in thrombosis and haemostasis. 3, S1, p. 354-355 2 p., PB0742.

    Research output: Contribution to journalMeeting AbstractAcademic

  4. Monitoring of heparins in antithrombin-deficient patients

    Croles, F. N., Lukens, M. V., Mulder, R., de Maat, M. P. M., Mulder, A. B. & Meijer, K., Mar-2019, In : Thrombosis Research. 175, p. 8-12 5 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  5. The DaXa-inhibition assay: A concept for a readily available, universal aXa assay that measures the direct inhibitory effect of all anti-Xa drugs

    van Pelt, L. J., Lukens, M. V., Testa, S., Chatelain, B., Douxfils, J. & Mullier, F., Aug-2018, In : Thrombosis Research. 168, p. 63-66 4 p.

    Research output: Contribution to journalLetterAcademicpeer-review

View all (20) »

ID: 14887955